CHRISTINE PACKARD: Open Payments
NPI 1427159904 · BOUNTIFUL, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,306 in 39 payments from 14 companies in 2025. Trend: 2023 $1,119 · 2024 $1,290 · 2025 $1,306
Food & beverage: $1,306
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 14 | $342 |
| UCB, Inc. | 3 | $187 |
| ABBVIE INC. | 4 | $173 |
| E.R. Squibb & Sons, L.L.C. | 4 | $137 |
| Janssen Biotech, Inc. | 1 | $125 |
| GENZYME CORPORATION | 1 | $122 |
| Regeneron Healthcare Solutions, Inc. | 3 | $60 |
| Incyte Corporation | 2 | $42 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $35 |
| LEO Pharma Inc. | 1 | $30 |
Products named: Bimzelx, COSENTYX, SKYRIZI, Sotyktu, TREMFYA, DUPIXENT, Rhapsido, LIBTAYO.
Industry payments across UT — which companies pay providers there.
